Detailed answers about ALLIGENT BIOPHARM CONSULTING (EUROPE) LIMITED, including incorporation, status, business activity, and accounts information.
When was ALLIGENT BIOPHARM CONSULTING (EUROPE) LIMITED founded?
ALLIGENT BIOPHARM CONSULTING (EUROPE) LIMITED was officially incorporated on 21 April 2016 and is registered under company number 10138701. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is ALLIGENT BIOPHARM CONSULTING (EUROPE) LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of ALLIGENT BIOPHARM CONSULTING (EUROPE) LIMITED?
ALLIGENT BIOPHARM CONSULTING (EUROPE) LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does ALLIGENT BIOPHARM CONSULTING (EUROPE) LIMITED do?
ALLIGENT BIOPHARM CONSULTING (EUROPE) LIMITED operates in the following sector: 74909 - Other professional, scientific and technical activities n.e.c.. This provides insight into the company's primary business activity and industry focus.
What is ALLIGENT BIOPHARM CONSULTING (EUROPE) LIMITED's registered address?
The registered office address of ALLIGENT BIOPHARM CONSULTING (EUROPE) LIMITED is ENVISION HOUSE, 5 NORTH STREET, HORSHAM, WEST SUSSEX, RH12 1XQ. This is the official address filed with Companies House for legal and statutory correspondence.
Is ALLIGENT BIOPHARM CONSULTING (EUROPE) LIMITED financially stable?
The most recent accounts for ALLIGENT BIOPHARM CONSULTING (EUROPE) LIMITED were made up to 31 December 2024, filed as AUDIT EXEMPTION SUBSIDIARY. Next accounts are due by 30 September 2026.
Does ALLIGENT BIOPHARM CONSULTING (EUROPE) LIMITED have any charges or mortgages?
ALLIGENT BIOPHARM CONSULTING (EUROPE) LIMITED has 4 registered charges, of which 4 are outstanding, 0 satisfied, and 0 part satisfied. Charges are typically registered when a company uses its assets as security for borrowing.
Has ALLIGENT BIOPHARM CONSULTING (EUROPE) LIMITED changed its name?
Yes, ALLIGENT BIOPHARM CONSULTING (EUROPE) LIMITED has had 1 previous name: TYROL ACQUISITIONCO LIMITED (changed 2 March 2017).